We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $5.3M Turnover 85.61%
1-Year Est. Return 7.8%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
Cap. Flow
-$186M
Cap. Flow %
-1,882.29%
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Avg Time Held
0.3 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ACVA icon
ACV Auctions
ACVA
+$194K
2
RPD icon
Rapid7
RPD
+$183K
3
EFC icon
Ellington Financial
EFC
+$181K
4
SAN icon
Banco Santander
SAN
+$159K
5
OSCR icon
Oscar Health
OSCR
+$155K

Top Sells

Rank Stock Value
1
EXLS icon
EXL Service
EXLS
+$830K
2
DK icon
Delek US
DK
+$724K
3
AVGO icon
Broadcom
AVGO
+$669K
4
ITRI icon
Itron
ITRI
+$666K
5
EAT icon
Brinker International
EAT
+$649K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.83%
2 Technology 15.87%
3 Healthcare 10.98%
4 Industrials 10.86%
5 Real Estate 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AXS icon
151
AXIS Capital
AXS
$7.27B
– –
-2,028
Closed -$217K –
AZ icon
152
A2Z Smart Technologies
AZ
$251M
– –
-16,379
Closed -$107K –
BB icon
153
BlackBerry
BB
$4.73B
– –
-26,445
Closed -$100K –
BCAL icon
154
Southern California Bancorp
BCAL
$700M
– –
-16,572
Closed -$309K –
BFAM icon
155
Bright Horizons
BFAM
$3.46B
– –
-4,103
Closed -$416K –
BFS icon
156
Saul Centers
BFS
$729M
– –
-7,862
Closed -$248K –
BFST icon
157
Business First Bancshares
BFST
$1.02B
– –
-11,334
Closed -$296K –
CMRC icon
158
Commerce.com Inc Series 1
CMRC
$285M
– –
-90,174
Closed -$372K –
BKD icon
159
Brookdale Senior Living
BKD
$2.41B
– –
-14,112
Closed -$152K –
BKSY icon
160
BlackSky Technology
BKSY
$709M
– –
-20,567
Closed -$386K –
BKU icon
161
Bankunited
BKU
$2.99B
– –
-5,454
Closed -$243K –
BLBD icon
162
Blue Bird Corp
BLBD
$1.95B
– –
-7,411
Closed -$348K –
BLZE icon
163
Backblaze
BLZE
$532M
– –
-36,502
Closed -$170K –
BMA icon
164
Banco Macro
BMA
$4.09B
– –
-2,870
Closed -$259K –
BMBL icon
165
Bumble
BMBL
$784M
– –
-14,880
Closed -$53.1K –
BMI icon
166
Badger Meter
BMI
$3.67B
– –
-1,953
Closed -$341K –
BMY icon
167
Bristol-Myers Squibb
BMY
$122B
– –
-3,762
Closed -$203K –
BOH icon
168
Bank of Hawaii
BOH
$2.65B
– –
-4,148
Closed -$284K –
BOOM icon
169
DMC Global
BOOM
$109M
– –
-20,078
Closed -$134K –
BRX icon
170
Brixmor Property Group
BRX
$8.49B
– –
-16,411
Closed -$430K –
BRZE icon
171
Braze
BRZE
$3.33B
– –
-15,150
Closed -$519K –
BSX icon
172
Boston Scientific
BSX
$64.3B
– –
-6,244
Closed -$595K –
BTCS icon
173
BTCS Inc
BTCS
$59.3M
– –
-66,722
Closed -$176K –
BTU icon
174
Peabody Energy
BTU
$2.91B
– –
-19,229
Closed -$571K –
BWB icon
175
Bridgewater Bancshares
BWB
$574M
– –
-14,216
Closed -$249K –

Similar funds

PharVision Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.

  • PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
  • PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
  • PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
  • PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
  • PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
  • PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
  • PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.